Tegmine
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4104 24th St Pmb 405, San Francisco, Cal...Website
www.tegminetx.comRevenue
<$5 MillionIndustry
About Tegmine
Tegmine Org Chart
Is Tegmine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Tegmine
Tegmine, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Tegmine launches new products
Earning: See what the market has to say on Tegmine recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Tegmine is spiking on competitors!
Funding: Get notified immidiatlly once Tegmine has new funding data
Check if Tegmine has recently received funding, and reach out quickly before it becomes old news!
Click to see if Tegmine had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Tegmine as Masked Content
Find 2 more new buyers
Compare Similar Companies to Tegmine
Compare insights from companies similar to Tegmine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tegmine is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tegmine is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tegmine.
Tegmine Tech Stack
A closer look at the technologies used by Tegmine
Tegmine News & Media
TegMine Therapeutics Enters Collaboration with Boehringer Ingelheim to Advance Novel 2-Factor Antibody System for Cancer
- Collaboration provides support for platform and funding to support development of safer, more-specific ADCs on up to three cancer targets - SAN FRANCISCO, Sept. 23, 2025 /PRNewswire/ -- TegMine Therapeutics, Inc., ("TegMine"), a biotechnology company focused on redefining precision...OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies
TAIPEI, Taiwan, June 06, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADCs) (4174. TWO), and TegMine Therapeutics, Inc. (TegMine), a US Biopharma specialized in developing best-in-class antibodies targeting cancer glycans and glycoproteins, have entered into an ADC-related Master Services Agreement (MSA).
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tegmine
Tegmine's vision is to restore hope and health for patients diagnosed with untreatable cancers. There have been great advances in cancer therapeutics, but theres still a lot of progress to be made. At Tegmine, weve developed a platform which employs cutting-edge mass spectrometry and CRISPR cell engineering to discover and develop of higher-specifi... Read More